| Manufacturer Name | Cat. no | Product Name | Clone | Quantity | Host Species | Specificity | Species Reactivity | Application | Immunogen | Product Type | Status | Recommened Dilution |
| DB Biotech | DB 001-0.05 | Anti - Actin | S12-I | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from C-terminal peptide of human β-actin | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:20 000 |
| DB Biotech | DB 002-0.1 | Anti - p53 | S11-K | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from C-terminal peptide of human p53 | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:20 000, ICC - 1:100 - 1:500 |
| DB Biotech | DB 002-0.05 | Anti - p53 | S11-K | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from C-terminal peptide of human p53 | monoclonal | primary | |
| DB Biotech | DB 003-0.1 | Anti - iNOS | K13-A | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from the human iNOS sequence | monoclonal | primary | WB - 1:2 000, ELISA - 1:20 000 - 1:50 000 |
| DB Biotech | DB 003-0.05 | Anti - iNOS | K13-A | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from the human iNOS sequence | monoclonal | primary | WB - 1:2 000, ELISA - 1:20 000 - 1:50 000 |
| DB Biotech | DB 004-0.1 | Anti - INTERFERON-γ | K14-B | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from C-terminal peptide of human Interferon-γ | monoclonal | primary | WB - 1:5 000, ELISA - 1:10 000 - 1:50 000 |
| DB Biotech | DB 004-0.05 | Anti - INTERFERON-γ | K14-B | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from C-terminal peptide of human Interferon-γ | monoclonal | primary | WB - 1:5 000, ELISA - 1:10 000 - 1:50 000 |
| DB Biotech | DB 005-0.1 | Anti - PKC-α | G13-R | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-α immunoafiinity purified clonal IgGs | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000-1:50 000, ICC - 1:100 - 1:200 |
| DB Biotech | DB 005-0.05 | Anti - PKC-α | G13-R | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-α immunoafiinity purified clonal IgGs | monoclonal | primary | |
| DB Biotech | DB 006-0.1 | Anti - PKC-βI | A10-F | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-βl sequence | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000 - 1:50 000, ICC - 1:100 - 1:300 |
| DB Biotech | DB 006-0.05 | Anti - PKC-βI | A10-F | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-βl sequence | monoclonal | primary | |
| DB Biotech | DB 007-0.1 | Anti - PKC-βII | N11-S | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-βll sequence | monoclonal | primary | WB - 1:10 000, ELISA - 1:20 000 - 1:100 000, ICC - 1:200 - 1:400 |
| DB Biotech | DB 007-0.05 | Anti - PKC-βII | N11-S | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-βll sequence | monoclonal | primary | |
| DB Biotech | DB 008-0.1 | Anti - PKC-γ | A12-H | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-γ sequence | monoclonal | primary | WB - 1:2 000, ELISA - 1:5 000 - 1:20 000, ICC - 1:100 - 1:500 |
| DB Biotech | DB 008-0.05 | Anti - PKC-γ | A12-H | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-γ sequence | monoclonal | primary | |
| DB Biotech | DB 009-0.1 | Anti - PKC-δ | K15-K | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from the human PKC-δ sequence | monoclonal | primary | WB - 1:1 000, ELISA - 1:5 000 - 1:10 000 |
| DB Biotech | DB 009-0.05 | Anti - PKC-δ | K15-K | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide derived from the human PKC-δ sequence | monoclonal | primary | WB - 1:1 000, ELISA - 1:5 000 - 1:10 000 |
| DB Biotech | DB 010-0.1 | Anti - PKC-ε | G13-X | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-ε sequence | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:50 000, ICC - 1:100 - 1:500 |
| DB Biotech | DB 010-0.05 | Anti - PKC-ε | G13-X | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-ε sequence | monoclonal | primary | |
| DB Biotech | DB 011-0.1 | Anti - PKC-ζ | R14-K | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-ζ sequence | monoclonal | primary | WB - 1:5 00, ELISA - 1:20 000 - 1:100 000, ICC - 1:100 - 1:400 |
| DB Biotech | DB 011-0.05 | Anti - PKC-ζ | R14-K | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the human PKC-ζ sequence | monoclonal | primary | |
| DB Biotech | DB 012-0.1 | Anti - Erk 1,2 | B20-U | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from C-terminal peptide of human Erk 2 | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000 - 1:100 000, ICC - 1:100 - 1:400 |
| DB Biotech | DB 012-0.05 | Anti - Erk 1,2 | B20-U | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from C-terminal peptide of human Erk 2 | monoclonal | primary | |
| DB Biotech | DB 013-0.1 | Anti - PHOSPHO-Erk 1,2 | G15-B | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the protein area including conserved pT-E-pY motif of activated Erk 1,2 | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000 - 1:100 000, ICC - 1:100 - 1:400 |
| DB Biotech | DB 013-0.05 | Anti - PHOSPHO-Erk 1,2 | G15-B | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP, ICC | peptide derived from the protein area including conserved pT-E-pY motif of activated Erk 1,2 | monoclonal | primary | |
| DB Biotech | DB 014-0.1 | Anti - METALLOTHIONEIN | N11-G | 100 ul | rabbit | human | human | WB, ELISA, IP | peptide corresponding to the N-Terminal sequence of human metallothionein (covering isoforms 1A, B,E,F,G,H, I, L, M, Q, S, Y, 2A) | monoclonal | primary | WB - 1:1 000, ELISA - 1:5 000 - 1:10 000 |
| DB Biotech | DB 014-0.05 | Anti - METALLOTHIONEIN | N11-G | 50 ul | rabbit | human | human | WB, ELISA, IP | peptide corresponding to the N-Terminal sequence of human metallothionein (covering isoforms 1A, B,E,F,G,H, I, L, M, Q, S, Y, 2A) | monoclonal | primary | WB - 1:1 000, ELISA - 1:5 000 - 1:10 000 |
| DB Biotech | DB 017-0.1 | Anti - NEPHRIN | Y17-R | 100 ul | rabbit | human | human,mouse, rat | WB, ELISA, IP | peptide derived from the centre of the fifth Ig-like domain of human nephrin | monoclonal | primary | WB - 1:5 000, ELISA - 1:50 000 - 1:100 000 |
| DB Biotech | DB 017-0.05 | Anti - NEPHRIN | Y17-R | 50 ul | rabbit | human | human,mouse, rat | WB, ELISA, IP | peptide derived from the centre of the fifth Ig-like domain of human nephrin | monoclonal | primary | WB - 1:5 000, ELISA - 1:50 000 - 1:100 000 |
| DB Biotech | DB 018-0.1 | Anti - CTRP5 | A14-A | 100 ul | rabbit | human | human, mouse | WB, ELISA, IP | peptide close to the amino terminus of human CTRP5 | monoclonal | primary | WB - 1:5 000, ELISA - 1:50 000 - 1:100 000 |
| DB Biotech | DB 018-0.05 | Anti - CTRP5 | A14-A | 50 ul | rabbit | human | human, mouse | WB, ELISA, IP | peptide close to the amino terminus of human CTRP5 | monoclonal | primary | WB - 1:5 000, ELISA - 1:50 000 - 1:100 000 |
| DB Biotech | DB 019-0.1 | Anti - CTRP7 | K14-S | 100 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide from near the carboxy terminus of human CTRP7 | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000 - 1:50 000 |
| DB Biotech | DB 019-0.05 | Anti - CTRP7 | K14-S | 50 ul | rabbit | human | human, rat, mouse-tested | WB, ELISA, IP | peptide from near the carboxy terminus of human CTRP7 | monoclonal | primary | WB - 1:5 000, ELISA - 1:20 000 - 1:50 000 |
| DB Biotech | DB 022-0.1 | Anti - TRYPSIN | A16-N | 100 ul | rabbit | human | human | WB, ELISA, IP | peptide derived from near the N terminus of human pancreatic cationic trypsin | monoclonal | primary | WB - 1:4 000, ELISA - 1:20 000 - 1:50 000 |
| DB Biotech | DB 022-0.05 | Anti - TRYPSIN | A16-N | 50 ul | rabbit | human | human | WB, ELISA, IP | peptide derived from near the N terminus of human pancreatic cationic trypsin | monoclonal | primary | WB - 1:4 000, ELISA - 1:20 000 - 1:50 000 |
| DB Biotech | DB 023-0.1 | Anti - TRYPSIN | G15-J | 100 ul | rabbit | human | human | WB, ELISA, IP | peptide derived from near the C terminus of human pancreatic cationic trypsin | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:20 000 |
| DB Biotech | DB 023-0.05 | Anti - TRYPSIN | G15-J | 50 ul | rabbit | human | human | WB, ELISA, IP | peptide derived from near the C terminus of human pancreatic cationic trypsin | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:20 000 |
| DB Biotech | DB 024-0.1 | Anti - NEPHRIN | G17-H | 100 ul | rabbit | human | human, mouse, rat | WB, ELISA, IP | peptide derived from the region near C terminus of first Ig-like domain of human nephrin (between residues Cys53-Cys101) | monoclonal | primary | WB - 1:2 000, ELISA - 1:20 000 - 1:50 000 |
| DB Biotech | DB 024-0.05 | Anti - NEPHRIN | G17-H | 50 ul | rabbit | human | human, mouse, rat | WB, ELISA, IP | peptide derived from the region near C terminus of first Ig-like domain of human nephrin (between residues Cys53-Cys101) | monoclonal | primary | WB - 1:2 000, ELISA - 1:10 000 - 1:20 000 |
| DB Biotech | DB 033-0.1 | Anti - PRION | T16-R | 100 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived from N-terminal peptide of human prion protein, just before the first octapeptide sequence repeat | monoclonal | primary | WB – 1:1 000, ELISA – 1:10 000 – 1:20 000 |
| DB Biotech | DB 033-0.05 | Anti - PRION | T16-R | 50 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived from N-terminal peptide of human prion protein, just before the first octapeptide sequence repeat | monoclonal | primary | WB – 1:1 000, ELISA – 1:10 000 – 1:20 000 |
| DB Biotech | DB 080-0.1 | Anti - PRION | V21-V | 100 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived the middle of the second α-helical domain of human prion protein | monoclonal | primary | WB – 1:1 000, ELISA – 1:20 000 – 1:50 000 |
| DB Biotech | DB 080-0.05 | Anti - PRION | V21-V | 50 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived the middle of the second α-helical domain of human prion protein | monoclonal | primary | WB – 1:1 000, ELISA – 1:20 000 – 1:50 000 |
| DB Biotech | DB 081-0.1 | Anti - PRION | C16-S | 100 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived the C-terminus of third α-helical domain of human prion protein | monoclonal | primary | WB – 1:2 000, ELISA – 1:20,000 – 1:50 000 |
| DB Biotech | DB 081-0.05 | Anti - PRION | C16-S | 50 ul | rabbit | human | human, ovine, bovine, mouse, rat - tested | WB, ELISA, IP | peptide derived the C-terminus of third α-helical domain of human prion protein | monoclonal | primary | WB – 1:2 000, ELISA – 1:20,000 – 1:50 000 |
| DB Biotech | DB 123-0.1 | Anti - BAX | GL8-R | 100 ul | rabbit | human | human, mouse, rat-tested | WB, ELISA, IP, ICC | peptide derived from the N-terminal sequence of human bax | monoclonal | primary | WB – 1:2 000, ELISA – 1:30 000 – 1:50 000, ICC 1:100 - 1:200 |
| DB Biotech | DB 123-0.05 | Anti - BAX | GL8-R | 50 ul | rabbit | human | human, mouse, rat-tested | WB, ELISA, IP, ICC | peptide derived from the N-terminal sequence of human bax | monoclonal | primary | |
| DB Biotech | DB 132-0.1 | Anti - Bcl-2 | P22-A | 100 ul | rabbit | human | uman, mouse, rat - tested | WB, ELISA, IP, ICC | peptide derived from the N-terminal sequence of human bcl2 | monoclonal | primary | WB– 1:5 000, ELISA – 1:50,000 – 1:100 000, ICC 1:100 - 1:300 |
| DB Biotech | DB 132-0.05 | Anti - Bcl-2 | P22-A | 50 ul | rabbit | human | Human, mouse, rat - tested | WB, ELISA, IP, ICC | peptide derived from the N-terminal sequence of human bcl2 | monoclonal | primary | |
| DB Biotech | DB 001-IHC-0.1 | Anti - Actin | S12-I | 100 ul | rabbit | human | | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | 1:100 - 1:200 |
| DB Biotech | DB 001-0.2 | Anti - Actin | S12-I | 200 ul | rabbit | human | | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | 1:100 - 1:200 |
| DB Biotech | DB 001-0.5 | Anti - Actin | S12-I | 500 ul | rabbit | human | | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | 1:100 - 1:200 |
| DB Biotech | DB 001-1 | Anti - Actin | S12-I | 1 ml | rabbit | human | | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | 1:100 - 1:200 |
| DB Biotech | DB 001-RTU-7 | Anti - Actin | S12-I | 7 ml RTU | rabbit | human | | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | ready to use |
| DB Biotech | DB 001-RTU-15 | Anti - Actin | S12-I | 15 ml RTU | rabbit | human | | IHC-P, IHC-Fr | peptide derived from C-terminal sequence of human β-actin | monoclonal | primary | ready to use |
| DB Biotech | DB 003-IHC-0.1 | Anti - iNOS | K13-A | 100 ul | rabbit | human | | IHC-P, IHC-Fr | peptide derived from human iNOS sequence | monoclonal | primary | 1:100 - 1:200 |
| DB Biotech | DB 003-0.2 | Anti - iNOS | K13-A | 200 ul | rabbit | human | | IHC-P, IHC-Fr | peptide derived from human iNOS sequence | monoclonal | primary | 1:100 - 1:200 |
| DB Biotech | DB 003-0.5 | Anti - iNOS | K13-A | 500 ul | rabbit | human | | IHC-P, IHC-Fr | peptide derived from human iNOS sequence | monoclonal | primary | 1:100 - 1:200 |
| DB Biotech | DB 003-1 | Anti - iNOS | K13-A | 1 ml | rabbit | human | | IHC-P, IHC-Fr | peptide derived from human iNOS sequence | monoclonal | primary | 1:100 - 1:200 |
